|
1
|
Chang DW, Satterfield WC, Son D, Neto N,
Madewell JE, Raymond AK, Patrick CW Jr, Miller MJ, Costelloe CM and
Weber KL: Use of vascularized periosteum or bone to improve healing
of segmental allografts after tumor resection: An ovine rib model.
Plast Reconstr Surg. 123:71–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sulciner ML, Serhan CN, Gilligan MM, Mudge
DK, Chang J, Gartung A, Lehner KA, Bielenberg DR, Schmidt B, Dalli
J, et al: Resolvins suppress tumor growth and enhance cancer
therapy. J Exp Med. 215:115–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheah CY, Seymour JF and Wang ML: Mantle
cell lymphoma. J Clin Oncol. 34:1256–1269. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Robak T, Huang H, Jin J, Zhu J, Liu T,
Samoilova O, Pylypenko H, Verhoef G, Siritanaratkul N, Osmanov E,
et al: Bortezomib-based therapy for newly diagnosed mantle-cell
lymphoma. N Engl J Med. 372:944–953. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ruan J, Martin P, Shah B, Schuster SJ,
Smith SM, Furman RR, Christos P, Rodriguez A, Svoboda J, Lewis J,
et al: Lenalidomide plus rituximab as initial treatment for
mantle-cell lymphoma. N Engl J Med. 373:1835–1844. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eskelund CW, Kolstad A, Jerkeman M, Räty
R, Laurell A, Eloranta S, Smedby KE, Husby S, Pedersen LB, Andersen
NS, et al: 15-year follow-up of the second nordic mantle cell
lymphoma trial (MCL2): Prolonged remissions without survival
plateau. Br J Haematol. 175:410–418. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hay N: Reprogramming glucose metabolism in
cancer: Can it be exploited for cancer therapy? Nat Rev Cancer.
16:635–649. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liberti MV and Locasale JW: The warburg
effect: How does it benefit cancer cells? Trends Biochem Sci.
41:211–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Olson AL and Pessin JE: Structure,
function, and regulation of the mammalian facilitative glucose
transporter gene family. Annu Rev Nutr. 16:235–256. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiao H, Wang J, Yan W, Cui Y, Chen Z, Gao
X, Wen X and Chen J: GLUT1 regulates cell glycolysis and
proliferation in prostate cancer. Prostate. 78:86–94. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oh S, Kim H, Nam K and Shin I: Glut1
promotes cell proliferation, migration and invasion by regulating
epidermal growth factor receptor and integrin signaling in
triple-negative breast cancer cells. BMB Rep. 50:132–137. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Neumann P, Jaé N, Knau A, Glaser SF,
Fouani Y, Rossbach O, Krüger M, John D, Bindereif A, Grote P, et
al: The lncRNA GATA6-AS epigenetically regulates endothelial gene
expression via interaction with LOXL2. Nat Commun. 9:2372018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu G, Gupta SK, Troska TP, Nair A and
Gupta M: Long non-coding RNA profile in mantle cell lymphoma
identifies a functional lncRNA ROR1-AS1 associated with EZH2/PRC2
complex. Oncotarget. 8:80223–80234. 2017.PubMed/NCBI
|
|
15
|
Wang X, Sehgal L, Jain N, Khashab T,
Mathur R and Samaniego F: LncRNA MALAT1 promotes development of
mantle cell lymphoma by associating with EZH2. J Transl Med.
14:3462016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vose JM: Mantle cell lymphoma: 2015 update
on diagnosis, risk-stratification, and clinical management. Am J
Hematol. 90:739–745. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zou ZW, Ma C, Medoro L, Chen L, Wang B,
Gupta R, Liu T, Yang XZ, Chen TT, Wang RZ, et al: LncRNA ANRIL is
up-regulated in nasopharyngeal carcinoma and promotes the cancer
progression via increasing proliferation, reprograming cell glucose
metabolism and inducing side-population stem-like cancer cells.
Oncotarget. 7:61741–61754. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu X and Gan B: lncRNA NBR2 modulates
cancer cell sensitivity to phenformin through GLUT1. Cell Cycle.
15:3471–3481. 2016. View Article : Google Scholar : PubMed/NCBI
|
